Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | OXTR | P30559 | 1/20 | 0.39 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.39 |
| ▸ | ACACB | O00763 | 4/20 | 0.37 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.37 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.37 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.37 |
| ▸ | KRAS | P01116 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3505257 | 0.85 | CACNB4 (0.45) | GPR119POLBNR1H2 | |
| SCHEMBL29497063 | 0.85 | LOXL2 (0.46) | ABHD6CYP11B2GPR119ACACBEHMT2 | |
| SCHEMBL25297104 | 0.85 | LOXL2 (0.46) | ABHD6CYP11B2GPR119ACACBEHMT2 | |
| SCHEMBL3505435 | 0.83 | GPR119 (0.53) | GPR119 | |
| SCHEMBL27149521 | 0.81 | ABHD6 (0.54) | ABHD6CYP11B2OXTRAVPR1AGPR119 | |
| SCHEMBL30721147 | 0.81 | ABHD6 (0.54) | ABHD6CYP11B2OXTRAVPR1AGPR119 | |
| SCHEMBL5671217 | 0.81 | PIK3CD (0.48) | GPR119 | |
| SCHEMBL9942549 | 0.79 | CHEK2 (0.45) | GPR119 | |
| SCHEMBL31080513 | 0.79 | CHEK2 (0.45) | GPR119 | |
| SCHEMBL9900492 | 0.79 | CHEK2 (0.45) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695238-A1 | CDK2 INHIBITORS | Blueprint Medicines Corporation (US) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024216154-A1 | CDK2 INHIBITORS | BLUEPRINT MEDICINES CORPORATION (US) | 2024-10-17 | — | — | WO | disclosed |